カテゴリ： Allied Market Research, 世界, 医療/バイオ

凝固検査のグローバル市場（2021〜2031）：器具、消耗品

■ 英語タイトル：Coagulation Testing Market By Product (Instruments, Consumables), By Application (Prothrombin Time, Activated Partial Thromboplastin Time, Thrombin Time, Activated Clotting Time), By End User (Hospitals, Clinical Laboratories, Point-of-Care Testing, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23FB218）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23FB218
■ 発行日：2022年10月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：280
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥521,220見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥836,580見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,401,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[凝固検査のグローバル市場（2021〜2031）：器具、消耗品]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本市場調査レポートでは、2021年に3,101.7百万ドルであった世界の凝固検査市場規模が、2031年までに8,777.3百万ドルに到達し、2022年から2031年にかけてCAGR（年平均成長率）11.5%で成長すると予測しています。本レポートは、凝固検査の世界市場を総合的に調査・分析した資料であり、イントロダクション、エグゼクティブサマリー、市場概要、製品別（器具、消耗品）分析、用途別（プロトロンビン時間、活性化部分トロンボプラスチン時間、トロンビン時間、活性化凝固時間）分析、エンドユーザー別（病院、臨床検査室、ポイントオブケア検査、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、企業状況、企業情報などを掲載しています。また、本レポートは、Alere Inc.、Nihon Kohden Corporation、F. Hoffmann-La Roche Ltd.、Sysmex Corporation、Thermo Fisher Scientific Inc.、Diagnostica Stago Sas、Helena Laboratoriesなどの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の凝固検査市場規模：製品別
- 凝固検査器具の市場規模
- 凝固検査消耗品の市場規模
・世界の凝固検査市場規模：用途別
- プロトロンビン時間における市場規模
- 活性化部分トロンボプラスチン時間における市場規模
- トロンビン時間における市場規模
- 活性化凝固時間における市場規模
・世界の凝固検査市場規模：エンドユーザー別
- 病院における市場規模
- 臨床検査室における市場規模
- ポイントオブケア検査における市場規模
- その他における市場規模
・世界の凝固検査市場規模：地域別
- 北米の凝固検査市場規模
- ヨーロッパの凝固検査市場規模
- アジア太平洋の凝固検査市場規模
- 中南米・中東・アフリカの凝固検査市場規模
・企業状況
・企業情報

世界の凝固検査市場規模は、2021年の31億1,070万ドルから2031年には87億7,730万ドルに拡大し、2022年から2031年までの年平均成長率は11.5%になると予測されています。

医療専門家は、凝固検査で止血システムを評価します。この検査には、血栓形成速度や血液凝固速度を監視・評価する凝固計が主に使用されます。これらの検査は、血液動脈の血栓の存在を検出することで、心臓発作、血栓症、塞栓症のリスクを低減します。

血流と血栓形成を制御する複雑なプロセスである止血（凝固）は、多数の酵素とタンパク質によって制御されています。
凝固検査機器の技術開発が進んだ結果、市場は拡大しています。凝固検査市場の主な成長要因は、深部静脈血栓症（DVT）や血友病を含むさまざまな血液凝固障害の有病率の上昇と、世界的な高齢化です。この市場は、世界の凝固検査市場の成長に関する調査で包括的に評価されています。
厳格な政府規制、検査や治療に伴う高いリスクとコストにより、経済的に可能な人口のみに使用が制限されていることが、世界の凝固検査市場に悪影響を与えています。
自己検査技術では、抗凝固療法を受ける患者の血流をモニターするのに役立つスマートフォンベースの血液凝固検査装置が市場の成長を牽引しています。これらの要因が凝固検査市場の需要を牽引しています。

COVID-19パンデミックは、多くの企業の世界的な操業停止の結果、大きな経済的損失をもたらした多くの困難をもたらしました。輸出入の制限が設けられました。COVID-19の流行は、世界の凝固検査市場に有益な影響を与えました。数多くの政府機関が、コロナウイルスの流行を乗り切るためにさまざまな対策を講じています。多くの政府機関が、コロナウイルスの流行から企業が生き残るために多くの行動を起こしています。

本レポートに掲載されている主要企業は、Thermo Fisher Scientific Inc.、Helena Laboratories Corporation、Micropoint Biosciences、Medtronic、F. Hoffmann-La Roche Ltd、日本光電工業株式会社、Abbott、Sysmex Corporation、BD Biosciences、Danaherなどです。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの凝固検査市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、優勢な凝固検査市場機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・凝固検査市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界の凝固検査市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
製品別
機器
消耗品

用途別
プロトロンビン時間
活性化部分トロンボプラスチン時間
トロンビン時間
活性化凝固時間

エンドユーザー別
病院
臨床検査室
ポイントオブケア検査
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
イギリス
フランス
スペイン
イタリア
その他のヨーロッパ
・アジア太平洋
中国
日本
インド
韓国
オーストラリア
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
アラブ首長国連邦
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Alere Inc.
日本光電工業株式会社
F. Hoffmann-La Roche Ltd.
Sysmex Corporation
Thermo Fisher Scientific Inc.
Diagnostica Stago Sas
Helena Laboratories
Abbott Laboratories
Medtronic plc
Micropoint Biosciences

*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Value Chain Analysis
3.8.Market Share Analysis
3.9.Regulatory Guidelines
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: COAGULATION TESTING MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Instruments
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Consumables
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: COAGULATION TESTING MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Prothrombin Time
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Activated Partial Thromboplastin Time
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Thrombin Time
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Activated Clotting Time
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: COAGULATION TESTING MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospitals
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Clinical Laboratories
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Point-of-Care Testing
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Others
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: COAGULATION TESTING MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product
7.2.3 North America Market size and forecast, by Application
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Product
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Product
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Product
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product
7.3.3 Europe Market size and forecast, by Application
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Product
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 United Kingdom
7.3.5.2.1 Market size and forecast, by Product
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 France
7.3.5.3.1 Market size and forecast, by Product
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Spain
7.3.5.4.1 Market size and forecast, by Product
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Italy
7.3.5.5.1 Market size and forecast, by Product
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Product
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Product
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Product
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Product
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Product
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Australia
7.4.5.5.1 Market size and forecast, by Product
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Product
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product
7.5.3 LAMEA Market size and forecast, by Application
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Product
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Product
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 UAE
7.5.5.3.1 Market size and forecast, by Product
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 South Africa
7.5.5.4.1 Market size and forecast, by Product
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by End User
7.5.5.5 Rest of LAMEA
7.5.5.5.1 Market size and forecast, by Product
7.5.5.5.2 Market size and forecast, by Application
7.5.5.5.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Alere Inc.
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Nihon Kohden Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Sysmex Corporation
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Thermo Fisher Scientific Inc.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Diagnostica Stago Sas
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Helena Laboratories
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Abbott Laboratories
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Medtronic plc
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Micropoint Biosciences
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 2. COAGULATION TESTING MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. COAGULATION TESTING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. COAGULATION TESTING MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 5. COAGULATION TESTING MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. GLOBAL COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 7. COAGULATION TESTING MARKET SIZE, FOR PROTHROMBIN TIME, BY REGION, 2021-2031 ($MILLION)
TABLE 8. COAGULATION TESTING MARKET FOR PROTHROMBIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 9. COAGULATION TESTING MARKET SIZE, FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2021-2031 ($MILLION)
TABLE 10. COAGULATION TESTING MARKET FOR ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. COAGULATION TESTING MARKET SIZE, FOR THROMBIN TIME, BY REGION, 2021-2031 ($MILLION)
TABLE 12. COAGULATION TESTING MARKET FOR THROMBIN TIME, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. COAGULATION TESTING MARKET SIZE, FOR ACTIVATED CLOTTING TIME, BY REGION, 2021-2031 ($MILLION)
TABLE 14. COAGULATION TESTING MARKET FOR ACTIVATED CLOTTING TIME, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. GLOBAL COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 16. COAGULATION TESTING MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 17. COAGULATION TESTING MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. COAGULATION TESTING MARKET SIZE, FOR CLINICAL LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 19. COAGULATION TESTING MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. COAGULATION TESTING MARKET SIZE, FOR POINT-OF-CARE TESTING, BY REGION, 2021-2031 ($MILLION)
TABLE 21. COAGULATION TESTING MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 22. COAGULATION TESTING MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 23. COAGULATION TESTING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 24. COAGULATION TESTING MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 25. NORTH AMERICA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 26. NORTH AMERICA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 29. U.S. COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 30. U.S. COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 31. U.S. COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 32. CANADA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 33. CANADA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 34. CANADA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 35. MEXICO COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 36. MEXICO COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. MEXICO COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. EUROPE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 39. EUROPE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 40. EUROPE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. EUROPE COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 42. GERMANY COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 43. GERMANY COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. GERMANY COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 45. UNITED KINGDOM COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 46. UNITED KINGDOM COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. UNITED KINGDOM COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 48. FRANCE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 49. FRANCE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. FRANCE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. SPAIN COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. SPAIN COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. SPAIN COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 54. ITALY COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 55. ITALY COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 56. ITALY COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. REST OF EUROPE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 58. REST OF EUROPE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 59. REST OF EUROPE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. ASIA-PACIFIC COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 61. ASIA-PACIFIC COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 62. ASIA-PACIFIC COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 64. CHINA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. CHINA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. CHINA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 67. JAPAN COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 68. JAPAN COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 69. JAPAN COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 70. INDIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 71. INDIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 72. INDIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. SOUTH KOREA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 74. SOUTH KOREA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 75. SOUTH KOREA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 77. AUSTRALIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 79. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 80. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 81. REST OF ASIA PACIFIC COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 82. LAMEA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 83. LAMEA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 84. LAMEA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. LAMEA COAGULATION TESTING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 86. BRAZIL COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 87. BRAZIL COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. BRAZIL COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 89. SAUDI ARABIA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 90. SAUDI ARABIA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 91. SAUDI ARABIA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 92. UAE COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. UAE COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 94. UAE COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 95. SOUTH AFRICA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 96. SOUTH AFRICA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 97. SOUTH AFRICA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 98. REST OF LAMEA COAGULATION TESTING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 99. REST OF LAMEA COAGULATION TESTING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 100. REST OF LAMEA COAGULATION TESTING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 101.ALERE INC.: COMPANY SNAPSHOT
TABLE 102.ALERE INC.: OPERATING SEGMENTS
TABLE 103.ALERE INC.: PRODUCT PORTFOLIO
TABLE 104.ALERE INC.: NET SALES,
TABLE 105.ALERE INC.: KEY STRATERGIES
TABLE 106.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 107.NIHON KOHDEN CORPORATION: OPERATING SEGMENTS
TABLE 108.NIHON KOHDEN CORPORATION: PRODUCT PORTFOLIO
TABLE 109.NIHON KOHDEN CORPORATION: NET SALES,
TABLE 110.NIHON KOHDEN CORPORATION: KEY STRATERGIES
TABLE 111.F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 112.F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
TABLE 113.F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 114.F. HOFFMANN-LA ROCHE LTD.: NET SALES,
TABLE 115.F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
TABLE 116.SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 117.SYSMEX CORPORATION: OPERATING SEGMENTS
TABLE 118.SYSMEX CORPORATION: PRODUCT PORTFOLIO
TABLE 119.SYSMEX CORPORATION: NET SALES,
TABLE 120.SYSMEX CORPORATION: KEY STRATERGIES
TABLE 121.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
TABLE 122.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
TABLE 123.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
TABLE 124.THERMO FISHER SCIENTIFIC INC.: NET SALES,
TABLE 125.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
TABLE 126.DIAGNOSTICA STAGO SAS: COMPANY SNAPSHOT
TABLE 127.DIAGNOSTICA STAGO SAS: OPERATING SEGMENTS
TABLE 128.DIAGNOSTICA STAGO SAS: PRODUCT PORTFOLIO
TABLE 129.DIAGNOSTICA STAGO SAS: NET SALES,
TABLE 130.DIAGNOSTICA STAGO SAS: KEY STRATERGIES
TABLE 131.HELENA LABORATORIES: COMPANY SNAPSHOT
TABLE 132.HELENA LABORATORIES: OPERATING SEGMENTS
TABLE 133.HELENA LABORATORIES: PRODUCT PORTFOLIO
TABLE 134.HELENA LABORATORIES: NET SALES,
TABLE 135.HELENA LABORATORIES: KEY STRATERGIES
TABLE 136.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 137.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 138.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 139.ABBOTT LABORATORIES: NET SALES,
TABLE 140.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 141.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 142.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 143.MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 144.MEDTRONIC PLC: NET SALES,
TABLE 145.MEDTRONIC PLC: KEY STRATERGIES
TABLE 146.MICROPOINT BIOSCIENCES: COMPANY SNAPSHOT
TABLE 147.MICROPOINT BIOSCIENCES: OPERATING SEGMENTS
TABLE 148.MICROPOINT BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 149.MICROPOINT BIOSCIENCES: NET SALES,
TABLE 150.MICROPOINT BIOSCIENCES: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ビデオ喉頭鏡のグローバル市場（2021〜2031）：固定型、汎用型
  • デジタル式血圧計のグローバル市場（2021〜2031）：腕型、手首型
  • 自家細胞治療のグローバル市場（2021〜2031）：がん、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23FB218 )"凝固検査のグローバル市場（2021〜2031）：器具、消耗品" (英文：Coagulation Testing Market By Product (Instruments, Consumables), By Application (Prothrombin Time, Activated Partial Thromboplastin Time, Thrombin Time, Activated Clotting Time), By End User (Hospitals, Clinical Laboratories, Point-of-Care Testing, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。